Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation

Journal of Nutritional Biochemistry

Volumn 18, Issue 5, 2007, Pages 297-304

  Cao, Dehua ^a   Yang, Bingya ^a   Hou, Lijuan ^a   Xu, Jun ^a   Xue, Renhao ^a   Sun, Liping ^a   Zhou, Chen ^a   Liu, Zhili ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Arachidonic acid; Brain damage; Cerebral edema; Ethyl docosahexaenoate; Na,K ATPase activity; Transient forebrain ischemia

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ETHYLDOCOSAHEXAENOATE; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN WATER; CAROTID ARTERY OBSTRUCTION; CHRONIC DRUG ADMINISTRATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVITY; FOREBRAIN; GERBIL; MALE; MORTALITY; NONHUMAN;

ANIMALS; ARACHIDONIC ACID; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; DOCOSAHEXAENOIC ACIDS; GERBILLINAE; MALE; NA(+)-K(+)-EXCHANGING ATPASE; POTASSIUM; SODIUM; SURVIVAL RATE;

ANIMALIA; GERBILLINAE;

EID: 34247126893     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.05.005     Document Type: Article

References (55)

1. Banzan N.G. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218 (1970) 1-10
2. Rehncrona S., Westerberg E., Åkesson B., and Siesjö B.K. Brain cortical fatty acid and phospholipids during and following complete and severe incomplete ischemia. J Neurochem 38 (1982) 84-93
3. Yoshida S., Ikeda M., Busto R., Santiso M., Martinez E., and Ginsberg M. Cerebral phosphoinositide, triacylglycerol and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J Neurochem 47 (1986) 744-757
4. Kubota M., Nakane M., Narita K., Nakagomi T., Tamura A., Hisaki H., et al. Mild hypothermia reduces the rate of metabolism of arachidonic acid following postishemic reperfusion. Brain Res 779 (1998) 297-300
5. Siesjö B.K., Katsura K., Zhao Q., Felbergrova S., Pahlmark K., Siesjö P., et al. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma 12 (1995) 943-956
6. +-ATPase activity in global cerebral ischemia-exposed rats. Prog NeuroPsychopharmacol Biol Psychiatry 26 (2002) 1319-1326
7. Zhang J.P., and Sun G.Y. Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia. J Neurochem 64 (1995) 1688-1695
8. Purdon A.D., Rosenberger T.A., Shetty H.U., and Rapoport S.I. Energy consumption by phospholipids metabolism in mammalian brain. Neurochem Res 27 (2002) 1641-1647
9. Rao A.M., Hatcher J.F., Kindy M.S., and Dempsey R.J. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res 24 (1999) 1225-1232
10. Blanco G., Sanchez G., and Mercer R.W. Differential regulation of Na, K-ATPase isozymes by protein kinases and arachidonic acid. Arch Biochem Biophys 359 (1998) 139-150
11. Macknight A.D.C., and Leaf A. Regulation of cellular volume. Physiol Rev 57 (1977) 510-573
12. Mrsulja B.B., Djuricic B.M., Cvejic V., Mrsulja B.J., Abe K., Spatz M., et al. Biochemistry of experimental ischemic brain edema. Adv Neurol 28 (1980) 217-230
13. Fenton W.S., Hibbeln J., and Knable M. Essential fatty acids, lipid membrane abnormalities and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47 (2000) 8-21
14. Salem Jr. N., Kim H.Y., and Yergey J.A. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A.P., Kifer R.R., and Martin R.E. (Eds). Health effects of polyunsaturated fatty acids in seafoods (1986), Academic Press, Orlando (Fla) 263-317
15. Glozman S., Green P., and Yavin E. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. J Neurochem 70 (1998) 2484-2491
16. Minami M., Kimura S., Endo T., Hamaue N., Hirafuji M., Monma Y., et al. Effects of dietary docosahexaenoic acid on survival time and stroke-related behavior in stroke-prone spontaneously hypertensive rats. Gen Pharmacol 29 (1997) 401-407
17. Okada M., Amamoto T., Tomonaga M., Kawachi A., Yazawa K., Mine K., et al. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 71 (1996) 17-25
18. Krokan H.E., Bjerve K.S., and Mork A. The central bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Biochim Biophys Acta 1168 (1993) 59-67
19. Cao D.H., Zhou C., Sun L.P., Xue R.H., Xu J., and Liu Z.L. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. J Nutr Biochem 17 (2006) 234-241
20. Minamisawa H., Mellergård P., Smith M.L., Bengtsson F., Theander S., Möller F.B., et al. Preservation of brain temperature during ischemia in rats. Stroke 21 (1990) 758-764
21. Levy D.E., and Duffy T.E. Effect of ischemia on energy metabolism in the gerbil cerebral cortex. J Neurochem 24 (1975) 1287-1289
22. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
23. Post R.L., and Sen A.K. Sodium and potassium-stimulated ATPase. Methods Enzymol 10 (1967) 762-768
24. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 66 (1925) 375-400
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
26. Calapia G., Squadrito F., Rizzo A., Marciano M.C., Campo G.M., and Caputi A.P. Multiple actions of the coumarin derivative cloricromene and its protective effects on ischemic brain injury. Naunyn-Schmiedeberg's Arch Pharmacol 351 (1995) 209-215
27. Lai M.L., Hsu C.Y., Liu T.H., He Y.Y., Xu J., Navidi M., et al. Effects of fish oil supplementation on acute ischemic brain injury in the rat. Neurology 43 (1993) 1227-1232
28. Patel P.M., Drummond J.C., Cole D.J., and Yaksh T.L. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. Brain Res 650 (1994) 205-211
29. Takeuchi Y., Morii H., Tamura M., Hayaishi O., and Watanabe Y. A possible mechanism of mitochondrial dysfunction during cerebral ischemia: inhibition of mitochondrial respiration activity by arachidonic acid. Arch Biochem Biophys 289 (1991) 33-38
30. 2 and C on free fatty acid release during complete ischemia in rat neocortex. J Neurosurg 76 (1992) 648-651
31. Sun D., and Gilboe D.D. Ischemia-induced changes in cerebral mitochondrial free fatty acids, phospholipids and respiration in the rats. J Neurochem 62 (1994) 1921-1928
32. Abe K., Kogure K., Yamamoto H., Imazawa M., and Miyamoto K. Mechanism of arachidonic acid liberation during ischemia in gerbil cortex. J Neurochem 48 (1987) 503-509
33. Rapoport S.I. In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways. Prostaglandins Other Lipid Mediat 77 (2005) 185-196
34. Pilitsis J.G., Diaz F.G., O'Regan M.H., and Phillis J.W. Differential effects of phospholipase inhibitors on free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Brain Res 951 (2002) 96-106
35. Gaetani P., Baena R.R., Marzatico F., Lombardi D., Knerich R., and Paoletti P. "Ex vivo" release of eicosanoid from human brain tissue: its relevance in the development of brain edema. Neurosurgery 28 (1991) 853-857
36. Ordway R.W., Walsh J.W., and Singer J.J. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science 244 (1989) 1176-1179
37. Zerangue N., Arriza J.L., Amar S.G., and Kavanaugh M.P. Differential modulation of human glutamate transporter subtypes by arachidonic acid. J Biol Chem 270 (1995) 6433-6435
38. 2+ pool in T cell through a mechanism independent of phosphoinositide turnover. J Biol Chem 15 (1990) 902-907
39. Bazán N.G. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv Exp Med Biol 72 (1976) 317-335
40. Lee H.J., Ghelardoni S., Chang L., Bosetti F., Rapoport S.I., and Bazinet R.P. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem Res 30 (2005) 677-683
41. 2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res 54 (1998) 805-813
42. Nagafuji T., Koide T., and Takato M. Neurochemical correlates of selective neuronal loss following cerebral ischemia: role of decreased Na, K-ATPase. Brain Res 571 (1992) 265-271
43. Lees G.J. Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brains Res Rev 16 (1991) 283-380
44. 2 and protein kinase C-dependent phosphorylation of the alpha-subunit. J Biol Chem 274 (1999) 2000-2008
45. Karmazyn M., Tuana B.S., and Dhalla N.S. Effect of prostaglandins on rat heart sarcolemmal ATPase. Can J Physiol Pharmacol 59 (1981) 1122-1127
46. Corey E.J., Shih C., and Cashman J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 80 (1983) 3581-3584
47. Lowe A.G. Functional aspects of active cation transport. In: Bittar E.E. (Ed). Membranes and ion transport (1971), Wiley-Interscience, London 251-277
48. Serhan C.N. Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 105 (2005) 7-21
49. Schuier F.J., and Hossmann K.A. Experimental brain infarcts in cats: 2. Ischemic brain edema. Stroke 11 (1980) 593-600
50. Adachi N., Namba C., Nagaro T., and Arai T. Dexamethasone reduces energy utilization in ischemic gerbil brain. Eur J Pharmacol 427 (2001) 119-123
51. Dempsey R.J., Roy M.W., Meyer K., Cowen D.E., and Tai H.H. Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg 64 (1986) 118-124
52. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278 (2003) 43807-43817
53. Green P., Glozman S., Weiner L., and Yavin E. Enhanced free radical scavenging and decreased lipid peroxidation in the fetal brain after treatment with ethyl docosahexaenoate. Biochim Biophys Acta 1532 (2001) 203-212
54. Cao D.H., Xu J.F., Xue R.H., Zheng W.F., and Liu Z.L. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav 79 (2004) 651-659
55. Wang X., Zhao X., Mao Z.Y., and Liu Z.L. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal culture. Neuroreport 14 (2003) 2457-2461